O111 SAFETY AND EFFICACY OF TREATMENT WITH THE INTERFERON-FREE, RIBAVIRIN-FREE COMBINATION OF SOFOSBUVIR + GS-5816 FOR 12 WEEKS IN TREATMENT NAIVE PATIENTS WITH GENOTYPE 1–6 HCV IN... von Everson, G.T, Tran, T.T, Towner, W.J, Davis, M.N, Wyles, D, Nahass, R, McNally, J, Brainard, D.M, Han, L, Doehle, B, Mogalian, E, Symonds, W.T, McHutchison, J.G, Morgan, T, Chung, R.T

Volltext

O166 ALL-ORAL DUAL THERAPY WITH DACLATASVIR AND ASUNAPREVIR IN PATIENTS WITH HCV GENOTYPE 1B INFECTION: PHASE 3 STUDY RESULTS von Manns, M, Pol, S, Jacobson, I, Marcellin, P, Gordon, S, Peng, C.-Y, Chang, T.-T, Everson, G, Heo, J, Gerken, G, Yoffe, B, Towner, W.J, Bourliere, M, Metivier, S, Chu, C.-J, Sievert, W, Bronowicki, J.-P, Thabut, D, Lee, Y.-J, Kao, J.-H, McPhee, F, Kopit, J, Mendez, P, Linaberry, M, Hughes, E, Noviello, S

Volltext